SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?


To: Richard Haugland who wrote (72)3/30/1998 8:06:00 AM
From: Richard Haugland  Read Replies (2) | Respond to of 359
 
[Axys Pharmaceuticals] has liquidated its equity holdings in Aurora Biosciences (Nasdaq: ABSC - news) in order to comply with the company's investment policies. The net proceeds of approximately $6.6 million will be reflected as an increase in cash and investments on the company's balance sheet.

biz.yahoo.com

That would be over 500,000 shares.